Latest Financials News

London City Equities reveals a strong half-year performance with an 18% rise in investment portfolio values and a favourable legal development involving Excelsior Capital. The company anticipates increased liquidity and is actively seeking new long-term investments.

Imperial Pacific reports a robust 17% increase in portfolio value for the half year ending December 2025, driven by gains in London City’s holdings and the strategic liquidation of Excelsior Capital. The company also paid a fully franked 7 cent dividend, signalling confidence despite pending audit reviews.

Eagle Mountain Mining has closed its entitlement offer, raising just over half of its targeted $1.98 million, with a significant shortfall to be placed alongside lead managers. The funds will support its copper-gold exploration projects in Arizona.

Recce Pharmaceuticals has received a $5.3 million R&D tax rebate from the Australian Taxation Office, providing a significant cash injection to support its innovative synthetic anti-infective drug development programs.

Atomic Eagle Limited has completed a 69-hole drilling program at its Chisebuka target in Zambia, revealing extensive shallow uranium mineralisation and setting the stage for a major resource upgrade across the Muntanga Project.

Little Green Pharma Ltd has agreed to acquire Cannatrek Ltd in a transformational merger that will create a leading vertically integrated medicinal cannabis group across Australia and Europe. The deal combines cultivation, manufacturing, distribution, clinics, and digital health platforms under one roof, positioning the combined entity for accelerated growth.

Polymetals Resources has resumed operations at its Endeavor Mine following a tragic incident, completing first concentrate shipments and securing $34.4 million in new capital to support exploration and ramp-up.

Stavely Minerals has initiated an updated 2026 Scoping Study for its copper-gold project in Western Victoria, driven by significantly higher metal prices and improved economic prospects since 2022.

Stellar Resources has reported significant progress in its December quarter, advancing the Heemskirk Tin Project through robust drilling results and metallurgical studies, supported by a $9.5 million capital raise.

HighCom Limited reveals a challenging first half of FY26 with losses linked to the US Government shutdown but signals a confident turnaround in the second half driven by diversification and operational improvements.

Great Dirt Resources has confirmed high-grade manganese mineralisation in NSW and identified 24 new exploration targets through advanced R&D techniques, supported by a $315k tax rebate and a strong cash position.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.